Skip to content

The Effect of Esmolol on Postoperative Pain in Patients Undergoing Bariatric Surgery: A Randomized Controlled Study

The Effect of Esmolol on Postoperative Pain in Patients Undergoing Bariatric Surgery: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117504
Enrollment
Unknown
Registered
2026-01-26
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The optimized management of acute postoperative pain following bariatric surgery

Interventions

Esmolol Group :A loading dose of esmolol (0.5mg/kg) was administered intravenously. Intravenous pump (0.05mg/ (kg·min))
Normal Saline Group:Intravenous injection of 0.9% Normal Saline

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 59 years old (inclusive of the boundary values). 2.Patients classified as ASA Physical Status Class I–III. 3.Patients scheduled to undergo bariatric surgery for gastric volume reduction. 4.Voluntarily participate in this study and sign the informed consent form. If the subject is unable to read the informed consent form (e.g., illiterate subjects), the informed consent process shall be witnessed by a third party, who will then sign the informed consent form along with the subject.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of drug abuse or opioid dependence. 2.Bronchial asthma or a history of bronchial asthma. 3.Severe chronic obstructive pulmonary disease (COPD). 4.Severe sinus bradycardia. 5.Second- to third-degree atrioventricular block. 6.Refractory cardiac insufficiency. 7.Cardiogenic shock. 8.Patients hypersensitive to esmolol. 9.Vulnerable groups excluding illiterate people, including critically ill patients, individuals with cognitive impairment, patients with mental disorders, pregnant women, etc. 10.Other circumstances where the investigator deems the subject unfit to participate in this study.

Design outcomes

Primary

MeasureTime frame
Postoperative opioid consumption within 72 hours;

Secondary

MeasureTime frame
Postoperative pain score;Quality of postoperative recovery;Adverse reaction;

Countries

China

Contacts

Public ContactZhao Hongyan

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China

zhythm@126.com+86 135 8806 6461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026